Biotest GmbH & Co. KGaA (HAM:BIO0)

Germany · Delayed Price · Currency is EUR

33.00

0.00 (0.00%)

At close: Jul 24, 2026

Biotest GmbH & Co. KGaA Financials Overview

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	648.9	648.9	726.2	684.6	516.1	515.6
Revenue Growth	-16.95%	-10.64%	6.08%	32.65%	0.10%	6.49%
Gross Profit	69.5	69.5	223.8	280.3	124.9	80.7
Operating Income	-56.5	-56.5	86.8	116.7	-20.2	-50.9
Net Income	-70.7	-70.7	26.4	127	-31.7	-63.4
Earnings Per Share	-1.79	-1.79	0.67	3.20	-0.80	-1.60
EPS Growth	-	-	-79.15%	-	-	-

Revenue by Geography

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Germany	600	600	684.8	616.2	393.2
Rest of World	48.9	48.9	41.4	68.4	122.8
Total	648.9	648.9	726.2	684.6	516

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	89.8	89.8	107.8	118.5	129	113.1
Total Debt	831.6	831.6	671.8	689.8	644.1	531.2
Net Cash (Debt)	-741.8	-741.8	-564	-571.3	-515.1	-418.1
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-18.75	-18.75	-14.25	-14.44	-13.02	-10.57

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-144.9	-144.9	60.9	-2.7	-40.5	33.8
Capital Expenditures	-11.6	-11.6	-28.7	-33.4	-29.3	-18.2
Free Cash Flow	-156.5	-156.5	32.2	-36.1	-69.8	15.6
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	10.71%	10.71%	30.82%	40.94%	24.20%	15.65%
Operating Margin	-8.71%	-8.71%	11.95%	17.05%	-3.91%	-9.87%
Pretax Margin	-14.38%	-14.38%	6.42%	15.53%	-5.99%	-12.16%
Profit Margin	-10.90%	-10.90%	3.64%	18.55%	-6.14%	-12.30%
FCF Margin	-24.12%	-24.12%	4.43%	-5.27%	-13.53%	3.03%

Dividends

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 25, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Dividend Per Share	0.040	0.040	0.040	0.040	-	0.040
Dividend Per Share Growth	0%	0%	0%	-	-	0%
Dividend Yield	0.12%	0.13%	-	-	-	-

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 25, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Forward PE	-	18.90	24.51	51.60	51.60	51.60
PS Ratio	2.01	2.22	-	-	-	-